Obesity and the polycystic ovary syndrome View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2002-06-25

AUTHORS

A Gambineri, C Pelusi, V Vicennati, U Pagotto, R Pasquali

ABSTRACT

The polycystic ovary syndrome (PCOS) is a condition characterized by hyperandrogenism and chronic oligo-anovulation. However, many features of the metabolic syndrome are inconsistently present in the majority of women with PCOS. Approximately 50% of PCOS women are overweight or obese and most of them have the abdominal phenotype. Obesity may play a pathogenetic role in the development of the syndrome in susceptible individuals. In fact, insulin possesses true gonadotrophic function and an increased insulin availability at the level of ovarian tissue may favour excess androgen synthesis. Obesity, particularly the abdominal phenotype, may be partly responsible for insulin resistance and associated hyperinsulinemia in women with PCOS. Therefore, obesity-related hyperinsulinemia may play a key role in favouring hyperandrogenism in these women. Other factors such as increased estrogen production rate, increased activity of the opioid system and of the hypothalamic-pituitary-adrenal axis, decreased sex hormone binding globulin synthesis and, possibly, high dietary lipid intake, may be additional mechanisms by which obesity favours the development of hyperandrogenism in PCOS. Irrespective of the pathogenetic mechanism involved, obese PCOS women have more severe hyperandrogenism and related clinical features (such as hirsutism, menstrual abnormalities and anovulation) than normal-weight PCOS women. This picture tends to be more pronounced in obese PCOS women with the abdominal phenotype.Body weight loss is associated with beneficial effects on hormones, metabolism and clinical features. A further clinical and endocrinological improvement can also be achieved by adding insulin-sensitizing agents and/or antiandrogens to weight reduction programmes. These obviously emphasize the role of obesity in the pathophysiology of PCOS. More... »

PAGES

883-896

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.ijo.0801994

DOI

http://dx.doi.org/10.1038/sj.ijo.0801994

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1036743149

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12080440


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1114", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Paediatrics and Reproductive Medicine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Androgens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Body Composition", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diet", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Estrogens", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Human Growth Hormone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Luteinizing Hormone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Obesity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Polycystic Ovary Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sex Hormone-Binding Globulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Somatomedins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "beta-Endorphin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.6292.f", 
          "name": [
            "Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gambineri", 
        "givenName": "A", 
        "id": "sg:person.0637327577.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637327577.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.6292.f", 
          "name": [
            "Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pelusi", 
        "givenName": "C", 
        "id": "sg:person.01022401230.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022401230.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.6292.f", 
          "name": [
            "Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vicennati", 
        "givenName": "V", 
        "id": "sg:person.01114343570.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114343570.39"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.6292.f", 
          "name": [
            "Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pagotto", 
        "givenName": "U", 
        "id": "sg:person.01022022532.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022022532.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy", 
          "id": "http://www.grid.ac/institutes/grid.6292.f", 
          "name": [
            "Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pasquali", 
        "givenName": "R", 
        "id": "sg:person.0600405520.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600405520.80"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.ijo.0801277", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014417478", 
          "https://doi.org/10.1038/sj.ijo.0801277"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03348145", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024870370", 
          "https://doi.org/10.1007/bf03348145"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.ijo.0801271", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008931532", 
          "https://doi.org/10.1038/sj.ijo.0801271"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03350782", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050663109", 
          "https://doi.org/10.1007/bf03350782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1177/107155769500200306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090631012", 
          "https://doi.org/10.1177/107155769500200306"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03350787", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047851668", 
          "https://doi.org/10.1007/bf03350787"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.ijo.0801281", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028384303", 
          "https://doi.org/10.1038/sj.ijo.0801281"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2002-06-25", 
    "datePublishedReg": "2002-06-25", 
    "description": "The polycystic ovary syndrome (PCOS) is a condition characterized by hyperandrogenism and chronic oligo-anovulation. However, many features of the metabolic syndrome are inconsistently present in the majority of women with PCOS. Approximately 50% of PCOS women are overweight or obese and most of them have the abdominal phenotype. Obesity may play a pathogenetic role in the development of the syndrome in susceptible individuals. In fact, insulin possesses true gonadotrophic function and an increased insulin availability at the level of ovarian tissue may favour excess androgen synthesis. Obesity, particularly the abdominal phenotype, may be partly responsible for insulin resistance and associated hyperinsulinemia in women with PCOS. Therefore, obesity-related hyperinsulinemia may play a key role in favouring hyperandrogenism in these women. Other factors such as increased estrogen production rate, increased activity of the opioid system and of the hypothalamic-pituitary-adrenal axis, decreased sex hormone binding globulin synthesis and, possibly, high dietary lipid intake, may be additional mechanisms by which obesity favours the development of hyperandrogenism in PCOS. Irrespective of the pathogenetic mechanism involved, obese PCOS women have more severe hyperandrogenism and related clinical features (such as hirsutism, menstrual abnormalities and anovulation) than normal-weight PCOS women. This picture tends to be more pronounced in obese PCOS women with the abdominal phenotype.Body weight loss is associated with beneficial effects on hormones, metabolism and clinical features. A further clinical and endocrinological improvement can also be achieved by adding insulin-sensitizing agents and/or antiandrogens to weight reduction programmes. These obviously emphasize the role of obesity in the pathophysiology of PCOS.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.ijo.0801994", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1035838", 
        "issn": [
          "0307-0565", 
          "1476-5497"
        ], 
        "name": "International Journal of Obesity", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "26"
      }
    ], 
    "keywords": [
      "polycystic ovary syndrome", 
      "obese PCOS women", 
      "PCOS women", 
      "abdominal phenotype", 
      "ovary syndrome", 
      "clinical features", 
      "pathophysiology of PCOS", 
      "high dietary lipid intake", 
      "normal-weight PCOS women", 
      "development of hyperandrogenism", 
      "role of obesity", 
      "related clinical features", 
      "dietary lipid intake", 
      "weight reduction program", 
      "body weight loss", 
      "insulin-sensitizing agents", 
      "majority of women", 
      "estrogen production rates", 
      "obesity-related hyperinsulinemia", 
      "associated hyperinsulinemia", 
      "severe hyperandrogenism", 
      "endocrinological improvement", 
      "metabolic syndrome", 
      "opioid system", 
      "insulin resistance", 
      "adrenal axis", 
      "pathogenetic role", 
      "lipid intake", 
      "sex hormones", 
      "pathogenetic mechanisms", 
      "insulin availability", 
      "androgen synthesis", 
      "hyperandrogenism", 
      "obesity", 
      "ovarian tissue", 
      "susceptible individuals", 
      "syndrome", 
      "gonadotrophic function", 
      "beneficial effects", 
      "weight loss", 
      "women", 
      "hyperinsulinemia", 
      "globulin synthesis", 
      "reduction programs", 
      "hormone", 
      "phenotype", 
      "additional mechanism", 
      "pathophysiology", 
      "insulin", 
      "intake", 
      "key role", 
      "role", 
      "tissue", 
      "metabolism", 
      "majority", 
      "agents", 
      "mechanism", 
      "individuals", 
      "levels", 
      "factors", 
      "development", 
      "activity", 
      "features", 
      "rate", 
      "loss", 
      "effect", 
      "resistance", 
      "improvement", 
      "program", 
      "axis", 
      "function", 
      "availability", 
      "synthesis", 
      "picture", 
      "conditions", 
      "fact", 
      "system", 
      "production rate"
    ], 
    "name": "Obesity and the polycystic ovary syndrome", 
    "pagination": "883-896", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1036743149"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.ijo.0801994"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12080440"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.ijo.0801994", 
      "https://app.dimensions.ai/details/publication/pub.1036743149"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T16:54", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_348.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.ijo.0801994"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.ijo.0801994'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.ijo.0801994'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.ijo.0801994'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.ijo.0801994'


 

This table displays all metadata directly associated to this object as RDF triples.

255 TRIPLES      21 PREDICATES      125 URIs      109 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.ijo.0801994 schema:about N02e3bb6cd23c48e990deb733ee9f76e2
2 N1c7eb9c7e2e14aa98fa65116e46c6258
3 N283b6e30adc24fc187105b44e04dfe30
4 N383eb9fb7b254285a91d9ae1a0ce244f
5 N3d69bb81cd0e416e89011b4a28ee7105
6 N40b7901dd9e3473287cf91a206332521
7 N566510310e5f43cd8a45e764d1246ee4
8 N648a9f7e434f4580938e93cde89633c9
9 N7b08015b1c0f4f9a8a9933579be96b16
10 N867ab01f65254beda689311d00aa82d7
11 N8741317fbc21495087b50f10ccb017b2
12 N8b165e3df7b445f89e57945281eefa05
13 Nc0cd4d96d2d5446ca65b4492a76ab475
14 Neb06ef39c84c49058ef323eefc7de9f8
15 anzsrc-for:11
16 anzsrc-for:1103
17 anzsrc-for:1114
18 schema:author Nb50a8b7071644651894c53b9b5af0bda
19 schema:citation sg:pub.10.1007/bf03348145
20 sg:pub.10.1007/bf03350782
21 sg:pub.10.1007/bf03350787
22 sg:pub.10.1038/sj.ijo.0801271
23 sg:pub.10.1038/sj.ijo.0801277
24 sg:pub.10.1038/sj.ijo.0801281
25 sg:pub.10.1177/107155769500200306
26 schema:datePublished 2002-06-25
27 schema:datePublishedReg 2002-06-25
28 schema:description The polycystic ovary syndrome (PCOS) is a condition characterized by hyperandrogenism and chronic oligo-anovulation. However, many features of the metabolic syndrome are inconsistently present in the majority of women with PCOS. Approximately 50% of PCOS women are overweight or obese and most of them have the abdominal phenotype. Obesity may play a pathogenetic role in the development of the syndrome in susceptible individuals. In fact, insulin possesses true gonadotrophic function and an increased insulin availability at the level of ovarian tissue may favour excess androgen synthesis. Obesity, particularly the abdominal phenotype, may be partly responsible for insulin resistance and associated hyperinsulinemia in women with PCOS. Therefore, obesity-related hyperinsulinemia may play a key role in favouring hyperandrogenism in these women. Other factors such as increased estrogen production rate, increased activity of the opioid system and of the hypothalamic-pituitary-adrenal axis, decreased sex hormone binding globulin synthesis and, possibly, high dietary lipid intake, may be additional mechanisms by which obesity favours the development of hyperandrogenism in PCOS. Irrespective of the pathogenetic mechanism involved, obese PCOS women have more severe hyperandrogenism and related clinical features (such as hirsutism, menstrual abnormalities and anovulation) than normal-weight PCOS women. This picture tends to be more pronounced in obese PCOS women with the abdominal phenotype.Body weight loss is associated with beneficial effects on hormones, metabolism and clinical features. A further clinical and endocrinological improvement can also be achieved by adding insulin-sensitizing agents and/or antiandrogens to weight reduction programmes. These obviously emphasize the role of obesity in the pathophysiology of PCOS.
29 schema:genre article
30 schema:isAccessibleForFree false
31 schema:isPartOf N2000aad8571b40c99fe875713acfc630
32 N217dc0a0d10d4572b9663bfac7bee897
33 sg:journal.1035838
34 schema:keywords PCOS women
35 abdominal phenotype
36 activity
37 additional mechanism
38 adrenal axis
39 agents
40 androgen synthesis
41 associated hyperinsulinemia
42 availability
43 axis
44 beneficial effects
45 body weight loss
46 clinical features
47 conditions
48 development
49 development of hyperandrogenism
50 dietary lipid intake
51 effect
52 endocrinological improvement
53 estrogen production rates
54 fact
55 factors
56 features
57 function
58 globulin synthesis
59 gonadotrophic function
60 high dietary lipid intake
61 hormone
62 hyperandrogenism
63 hyperinsulinemia
64 improvement
65 individuals
66 insulin
67 insulin availability
68 insulin resistance
69 insulin-sensitizing agents
70 intake
71 key role
72 levels
73 lipid intake
74 loss
75 majority
76 majority of women
77 mechanism
78 metabolic syndrome
79 metabolism
80 normal-weight PCOS women
81 obese PCOS women
82 obesity
83 obesity-related hyperinsulinemia
84 opioid system
85 ovarian tissue
86 ovary syndrome
87 pathogenetic mechanisms
88 pathogenetic role
89 pathophysiology
90 pathophysiology of PCOS
91 phenotype
92 picture
93 polycystic ovary syndrome
94 production rate
95 program
96 rate
97 reduction programs
98 related clinical features
99 resistance
100 role
101 role of obesity
102 severe hyperandrogenism
103 sex hormones
104 susceptible individuals
105 syndrome
106 synthesis
107 system
108 tissue
109 weight loss
110 weight reduction program
111 women
112 schema:name Obesity and the polycystic ovary syndrome
113 schema:pagination 883-896
114 schema:productId N1300e9a70fe14c338a02357f1e3ec244
115 N17e2f4814ac244a185e20505bfab152b
116 Nc18b4c857d5b4ce389d34ab21567f055
117 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036743149
118 https://doi.org/10.1038/sj.ijo.0801994
119 schema:sdDatePublished 2022-08-04T16:54
120 schema:sdLicense https://scigraph.springernature.com/explorer/license/
121 schema:sdPublisher Nfa37d49eafca4525997f0f5c00f62796
122 schema:url https://doi.org/10.1038/sj.ijo.0801994
123 sgo:license sg:explorer/license/
124 sgo:sdDataset articles
125 rdf:type schema:ScholarlyArticle
126 N02e3bb6cd23c48e990deb733ee9f76e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Somatomedins
128 rdf:type schema:DefinedTerm
129 N1300e9a70fe14c338a02357f1e3ec244 schema:name doi
130 schema:value 10.1038/sj.ijo.0801994
131 rdf:type schema:PropertyValue
132 N17e2f4814ac244a185e20505bfab152b schema:name pubmed_id
133 schema:value 12080440
134 rdf:type schema:PropertyValue
135 N1c7eb9c7e2e14aa98fa65116e46c6258 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Body Composition
137 rdf:type schema:DefinedTerm
138 N2000aad8571b40c99fe875713acfc630 schema:issueNumber 7
139 rdf:type schema:PublicationIssue
140 N217dc0a0d10d4572b9663bfac7bee897 schema:volumeNumber 26
141 rdf:type schema:PublicationVolume
142 N283b6e30adc24fc187105b44e04dfe30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Luteinizing Hormone
144 rdf:type schema:DefinedTerm
145 N37d848db887f425b8c5733f1b395ba7d rdf:first sg:person.01114343570.39
146 rdf:rest N722c86f7acbd4c94a8ace1cf564f4d43
147 N383eb9fb7b254285a91d9ae1a0ce244f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Diet
149 rdf:type schema:DefinedTerm
150 N3c703b4964cb4ed6b3376a80a427c71c rdf:first sg:person.01022401230.14
151 rdf:rest N37d848db887f425b8c5733f1b395ba7d
152 N3d69bb81cd0e416e89011b4a28ee7105 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Polycystic Ovary Syndrome
154 rdf:type schema:DefinedTerm
155 N40b7901dd9e3473287cf91a206332521 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Humans
157 rdf:type schema:DefinedTerm
158 N566510310e5f43cd8a45e764d1246ee4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Androgens
160 rdf:type schema:DefinedTerm
161 N648a9f7e434f4580938e93cde89633c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Female
163 rdf:type schema:DefinedTerm
164 N722c86f7acbd4c94a8ace1cf564f4d43 rdf:first sg:person.01022022532.33
165 rdf:rest Ne1a9e9fa4c324f2db050a771ddc9bf72
166 N7b08015b1c0f4f9a8a9933579be96b16 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Estrogens
168 rdf:type schema:DefinedTerm
169 N867ab01f65254beda689311d00aa82d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Sex Hormone-Binding Globulin
171 rdf:type schema:DefinedTerm
172 N8741317fbc21495087b50f10ccb017b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name beta-Endorphin
174 rdf:type schema:DefinedTerm
175 N8b165e3df7b445f89e57945281eefa05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Insulin
177 rdf:type schema:DefinedTerm
178 Nb50a8b7071644651894c53b9b5af0bda rdf:first sg:person.0637327577.43
179 rdf:rest N3c703b4964cb4ed6b3376a80a427c71c
180 Nc0cd4d96d2d5446ca65b4492a76ab475 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Obesity
182 rdf:type schema:DefinedTerm
183 Nc18b4c857d5b4ce389d34ab21567f055 schema:name dimensions_id
184 schema:value pub.1036743149
185 rdf:type schema:PropertyValue
186 Ne1a9e9fa4c324f2db050a771ddc9bf72 rdf:first sg:person.0600405520.80
187 rdf:rest rdf:nil
188 Neb06ef39c84c49058ef323eefc7de9f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Human Growth Hormone
190 rdf:type schema:DefinedTerm
191 Nfa37d49eafca4525997f0f5c00f62796 schema:name Springer Nature - SN SciGraph project
192 rdf:type schema:Organization
193 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
194 schema:name Medical and Health Sciences
195 rdf:type schema:DefinedTerm
196 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
197 schema:name Clinical Sciences
198 rdf:type schema:DefinedTerm
199 anzsrc-for:1114 schema:inDefinedTermSet anzsrc-for:
200 schema:name Paediatrics and Reproductive Medicine
201 rdf:type schema:DefinedTerm
202 sg:journal.1035838 schema:issn 0307-0565
203 1476-5497
204 schema:name International Journal of Obesity
205 schema:publisher Springer Nature
206 rdf:type schema:Periodical
207 sg:person.01022022532.33 schema:affiliation grid-institutes:grid.6292.f
208 schema:familyName Pagotto
209 schema:givenName U
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022022532.33
211 rdf:type schema:Person
212 sg:person.01022401230.14 schema:affiliation grid-institutes:grid.6292.f
213 schema:familyName Pelusi
214 schema:givenName C
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01022401230.14
216 rdf:type schema:Person
217 sg:person.01114343570.39 schema:affiliation grid-institutes:grid.6292.f
218 schema:familyName Vicennati
219 schema:givenName V
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114343570.39
221 rdf:type schema:Person
222 sg:person.0600405520.80 schema:affiliation grid-institutes:grid.6292.f
223 schema:familyName Pasquali
224 schema:givenName R
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600405520.80
226 rdf:type schema:Person
227 sg:person.0637327577.43 schema:affiliation grid-institutes:grid.6292.f
228 schema:familyName Gambineri
229 schema:givenName A
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0637327577.43
231 rdf:type schema:Person
232 sg:pub.10.1007/bf03348145 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024870370
233 https://doi.org/10.1007/bf03348145
234 rdf:type schema:CreativeWork
235 sg:pub.10.1007/bf03350782 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050663109
236 https://doi.org/10.1007/bf03350782
237 rdf:type schema:CreativeWork
238 sg:pub.10.1007/bf03350787 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047851668
239 https://doi.org/10.1007/bf03350787
240 rdf:type schema:CreativeWork
241 sg:pub.10.1038/sj.ijo.0801271 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008931532
242 https://doi.org/10.1038/sj.ijo.0801271
243 rdf:type schema:CreativeWork
244 sg:pub.10.1038/sj.ijo.0801277 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014417478
245 https://doi.org/10.1038/sj.ijo.0801277
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/sj.ijo.0801281 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028384303
248 https://doi.org/10.1038/sj.ijo.0801281
249 rdf:type schema:CreativeWork
250 sg:pub.10.1177/107155769500200306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090631012
251 https://doi.org/10.1177/107155769500200306
252 rdf:type schema:CreativeWork
253 grid-institutes:grid.6292.f schema:alternateName Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy
254 schema:name Department of Internal Medicine, Endocrinology Unit, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum, Bologna, Italy
255 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...